Palivizumab

ATC J06BD01 · 8 markets · 20 records

Palivizumab 8 markets · 20 records Forms

GB 4 records · 4 strengths

100 mginjectionSynagis 100mg powder and solvent for solution for injection vials also in AU
50 mginjectionSynagis 100mg powder and solvent for solution for injection vials also in AU
100 mg/1 mLinjectionSynagis 50mg/0.5ml solution for injection vials
50 mg/0.5 mLinjectionSynagis 50mg/0.5ml solution for injection vials

AU 3 records · 3 strengths

100 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial also in GB unknown
50 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial also in GB unknown

Records without a stated strength · 1 SYNAGIS

HK 2 records · 1 strengths

Records without a stated strength · 1 SYNAGIS SOLUTION FOR INJECTION 100MG/1ML

SG 1 records · 1 strengths

100 mg/mLinjectionSYNAGIS SOLUTION FOR INJECTION 100MG/ML

TW 1 records · 1 strengths

Records without a stated strength · 1 SYNAGIS 100mg/ml solution for injection、西那吉斯注射液劑100毫克/毫升

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 SYNAGIS

Side-by-side table

Strength / form / release	GB	AU	SG	TW	HK	EU
100 mg injection	Synagis 100mg powder and solvent for solution for injection vials	SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial	not recorded	not recorded	not recorded	not recorded
50 mg injection	Synagis 100mg powder and solvent for solution for injection vials	SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial	not recorded	not recorded	not recorded	not recorded
100 mg/1 mL injection	Synagis 50mg/0.5ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg/mL injection	not recorded	not recorded	SYNAGIS SOLUTION FOR INJECTION 100MG/ML	not recorded	not recorded	not recorded
50 mg/0.5 mL injection	Synagis 50mg/0.5ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	SYNAGIS	not recorded	not recorded	SYNAGIS SOLUTION FOR INJECTION 100MG/1ML	SYNAGIS
not disclosed injection	not recorded	not recorded	not recorded	SYNAGIS 100mg/ml solution for 西那吉斯注射液劑100毫克/毫升	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录（未在本表显示）。另有 1 個規格/劑型僅在 SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.